Clinical Research Directory
Browse clinical research sites, groups, and studies.
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
Sponsor: Centre Georges Francois Leclerc
Summary
5 to 10% of cancers are due to the presence of a constitutional genetic alteration. It can be inherited from parents (family form) or by accident, in the first moments of life after fertilization (sporadic form). In both cases, this genetic alteration is constitutional and transmissible to descendants. It is hereditary. When an hereditary early form is suspected, several well-known genes generally involved in genetic predispositions to cancer are found by a technique called " gene panel ". However, this analysis does not always identify the genetic predisposing factors for cancer. New techniques called "high-throughput exome sequencing (SHD-E)", allow more than the analysis of the the gene panel. These analysis allow to identify alterations in other genes that could contribute to the development of cancer. The objective of the Ex²trican study is to show, from patients with early cancer (sporadic or familial form), that this approach to exome sequencing can be effective to identify new genetic risk of cancer, when the first panel analysis of genes is negative.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
613
Start Date
2019-10-07
Completion Date
2028-04-07
Last Updated
2026-04-03
Healthy Volunteers
No
Conditions
Interventions
blood sample
blood test
Locations (6)
CHRU Jean Minjoz
Besançon, France
Centre Georges-François Leclerc
Dijon, France
CHU de Dijon
Dijon, France
CHU de Reims
Reims, France
Polyclinique de Courlancy
Reims, France
CH de Troyes
Troyes, France